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Pre-mRNA splicing not only removes introns and joins exons to
generate splicedmRNAbut also results in remodeling of the spliced
messenger ribonucleoprotein, influencing various downstream
events. This remodeling includes the loading of an exon–exon
junction complex (EJC). It is unclear how the spliceosome recruits
the EJC onto the mRNA and whether EJC formation or EJC com-
ponents are required for pre-mRNA splicing. Here we immunode-
pleted the EJC core component eIF4A3 from HeLa cell nuclear
extract and found that eIF4A3 is dispensable for pre-mRNA splicing
in vitro. However, eIF4A3 is required for the splicing-dependent
loading of the Y14/Magoh heterodimer onto mRNA, and this
activity of human eIF4A3 is also present in theDrosophila ortholog.
Surprisingly, the loading of six other EJC components was not
affected by eIF4A3 depletion, suggesting that their binding to
mRNA involves different or redundant pathways. Finally,we found
that the assembly of the EJC onto mRNA occurs at the late stages
of the splicing reaction and requires the second-step splicing
and mRNA-release factor HRH1/hPrp22. The EJC-dependent and
-independent recruitment of RNA-binding proteins onto mRNA
suggests a role for the EJC in messenger ribonucleoprotein remod-
eling involving interactions with other proteins already bound to
the pre-mRNA, which has implications for nonsense-mediated
mRNA decay and other mRNA transactions.
messenger ribonucleoprotein remodeling  nonsense-mediated mRNA
decay  pre-mRNA splicing
Eukaryotic gene expression requires elaborate posttranscrip-tional control mechanisms to ensure that the genetic informa-
tion is precisely transferred from DNA to its final products. The
quality control of mRNA synthesis plays a central role in this
process (1). During pre-mRNA splicing, introns are removed by the
spliceosome, and the exons are ligated to form the mature mRNA.
Splicing also affects many other aspects of downstream events,
including mRNA export, surveillance, localization, and translation
(2). These effects have been linked to the recruitment of specific
proteins onto the mRNA during splicing, with the consequent
remodeling of the messenger ribonucleoprotein (mRNP) compo-
sition and structure.
The exon–exon junction complex (EJC) is loaded onto the newly
spliced mRNA 20–24 nt upstream of exon–exon junctions in a
sequence nonspecific manner (3, 4). Several EJC factors are
essential for mRNA localization in oocytes (5), nonsense-mediated
mRNA decay (NMD) (5–7), and translational enhancement (8).
The crystal structure of an EJC core complex, assembled from
individual recombinant proteins and an RNA fragment, provided
important details about how the complex is organized and stably
binds to its RNA target (9, 10). However, the EJC is normally
loaded onto mRNA during the course of pre-mRNA splicing (3),
and the molecular mechanisms responsible for splicing-coupled
loading of the EJC remain unknown.
Among the EJC components, the ATP-dependent DEAD-box
RNA helicase eIF4A3 was proposed to be the key factor in
formation of the complex (11), in part because it directly contacts
the RNA in the EJC core (7, 9, 10). eIF4A3 is loaded onto mRNA
during splicing, but it was not known whether it is essential for
pre-mRNA splicing. RNA helicases are involved in many different
aspects of RNA metabolism (12). During splicing, the extensive
rearrangements and remodeling of the small nuclear RNAs and
proteins of the spliceosome occur in an ATP-dependent manner,
reflecting the involvement of various RNA helicases required for
splicing, including Prp5, Prp18, Prp22, Prp19, and UAP56 (13).
eIF4A3, as well as Y14/Magoh, were identified by mass spectrom-
etry as components of purified human spliceosomes (14, 15). Unlike
other helicases that function in splicing, eIF4A3 becomes tightly
associated with spliced mRNA and plays critical roles in several
postsplicing events. It is therefore of interest to determine whether
eIF4A3 and other EJC factors play a role in pre-mRNA splicing, as
well as to establish the mechanisms by which these factors are
loaded onto mRNA. Although pre-mRNA splicing appears to be
unaffected by RNAi knockdown of eIF4A3 (6, 8), detailed mech-
anistic analysis in vitro is warranted, because several biochemically
well characterized essential splicing factors also appear to be
dispensable for splicing in vivo after RNAi knockdown (16, 17).
Here we show that eIF4A3 is dispensable for pre-mRNA splicing
in vitro despite its splicing-dependent association with the spliceo-
some. We also found that eIF4A3 is required for loading of
Y14/Magoh onto mRNA by the spliceosome. Surprisingly, we
found that binding of other EJC components onto mRNA does not
require eIF4A3, because several factors previously thought to be
recruited by the EJC could be loaded onto mRNA independently
of EJC assembly. Finally, we show that eIF4A3 assembles onto the
EJC at the late stages of splicing and that EJC assembly requires the
helicase activity of HRH1/hPrp22.
Results
eIF4A3 Is Not Required for Pre-mRNA Splicing in Vitro.To characterize
the role of eIF4A3 in splicing, we generated a mouse monoclonal
antibody against human eIF4A3 [supporting information (SI) Fig.
5]. We used this antibody to immunodeplete eIF4A3 from HeLa
nuclear extract (NE). In high-salt conditions (750 mM KCl), we
depleted95% of eIF4A3, compared with a control depletion with
an antibody against Escherichia coli maltose-binding protein (Fig.
1A, lanes 1–3). There was no significant change in the amount of
several control proteins, including PUF60, SF2/ASF, and U2-B
(Fig. 1A, lanes 1–3). In addition, another EJC core component,
Y14, was not codepleted with eIF4A3 under these conditions (Fig.
1B), suggesting that the EJC core complex is disrupted in high salt.
Author contributions: Z.Z. and A.R.K. designed research; Z.Z. performed research; Z.Z. and
A.R.K. analyzed data; and Z.Z. and A.R.K. wrote the paper.
The authors declare no conflict of interest.
Abbreviations: NMD, nonsense-mediated mRNA decay; EJC, exon–exon junction complex;
mRNP, messenger ribonucleoprotein; PTC, premature termination codon; NE, nuclear
extract.
*To whom correspondence should be addressed at: Cold Spring Harbor Laboratory, P.O.
Box 100, Cold Spring Harbor, NY 11724. E-mail: krainer@cshl.edu.
This article contains supporting information online at www.pnas.org/cgi/content/full/
0704946104/DC1.
© 2007 by The National Academy of Sciences of the USA
11574–11579  PNAS  July 10, 2007  vol. 104  no. 28 www.pnas.orgcgidoi10.1073pnas.0704946104
We then tested whether the eIF4A3-depleted (4A3) NE is still
functional in pre-mRNA splicing. An in vitro splicing time course
with human -globin pre-mRNA showed that control-depleted
(mock) and 4A3 NE had essentially equivalent splicing activity
(Fig. 1C, compare lanes 5–8 with lanes 9–12). Adding back purified
His-tagged recombinant eIF4A3 expressed inE. coli did not change
the splicing activity (Fig. 1C, lanes 13–16). The control-depleted
and 4A3 NE were equally active with other substrates, e.g., IgM
C3-C4, Ftz, and AdML pre-mRNAs (Fig. 1D). We conclude that
eIF4A3 is dispensable for constitutive pre-mRNA splicing despite
its known association with the spliceosome. We also tested a model
substrate derived from human -globin pre-mRNA with a dupli-
cated 5 splice site (18) and found that eIF4A3 was not required for
modulating 5 splice site selection in response to an increase in
(Ser/Arg-rich) protein levels (SI Fig. 6).
eIF4A3 Is Essential for Loading Y14/Magoh onto Spliced mRNA. To
study the role of eIF4A3 in EJC assembly, we used an in vitro assay
to measure EJC loading coupled with pre-mRNA splicing. We
purified GST-tagged eIF4A3, added the protein to in vitro splicing
reactions with HeLa NE, and then carried out GST pull-down
assays to detect the bound RNAs (19, 20). We used GST-Y14/His-
Magoh heterodimer as a control. After splicing, Y14/Magoh and
eIF4A3 specifically pulled down spliced mRNA but only trace
amounts of pre-mRNA and intron lariat (SI Fig. 7A, lanes 9 and 10).
A small amount of the 5 exon was also pulled down, consistent with
a report that the 5 exon provides the binding surface for EJC
assembly (21).
Using an RNase H cleavage assay (3), we verified that GST-
eIF4A3 and GST-Y14/His-Magoh are loaded onto mRNA up-
stream of the exon–exon junction during splicing (SI Fig. 7). We
next sought to determine the effect of eIF4A3 depletion on EJC
assembly. Although eIF4A3 and Y14/Magoh interact (19), how
each affects the other’s loading onto mRNA was not known. We
carried out the above splicing-dependent loading assay using 4A3
NE. In the absence of eIF4A3, the Y14/Magoh heterodimer was no
longer loaded onto mRNA (Fig. 2A, compare lanes 7 and 8). We
then added purified recombinant His-tagged eIF4A3 to the 4A3
NE and carried out the GST pull-down assay; as the amount of
eIF4A3 added increased, the loading of Y14/Magoh onto spliced
mRNA was fully restored (Fig. 2B, lanes 12–16). This depletion/
add-back experiment demonstrates that Y14/Magoh loading onto
spliced mRNA requires eIF4A3, suggesting a central role for
eIF4A3 in EJC assembly during pre-mRNA splicing.
We then performed the pull-down assays in depleted extract after
adding back different mutant forms of human eIF4A3 or its
orthologs. Two mutant versions of eIF4A3, K88A and S218L, which
lack helicase activity (19), were still active in the Y14/Magoh
loading complementation assay, with perhaps a slight decrease in
activity compared with the WT (Fig. 2C, lanes 12–14), whereas an
Fig. 1. eIF4A3 is dispensable for pre-mRNA splicing in vitro. (A) Endogenous
eIF4A3 is efficiently immunodepleted fromHeLaNE. eIF4A3 and the indicated
control proteins were detected by Western blotting. AK105 is a control
monoclonal antibody against bacterial maltose-binding protein. (B) The EJC
component Y14 and the small nuclear RNP protein U2-B are not codepleted
with eIF4A3 under these conditions. (C) In vitro splicing time course with
human -globin pre-mRNA in untreated NE (lanes 1–4), mock-depleted NE
(lanes 5–8), and eIF4A3-depleted NE (4A3 NE) without (lanes 9–12) or with
(lanes 13–16) added recombinant His-tagged eIF4A3 (80 ng). The pre-mRNA,
mRNA, and intermediates are indicated. (D) In vitro splicing assays with
-globin, IgM C3-C4, Ftz, and AdML pre-mRNAs in mock-depleted and 4A3
NE. The arrowheads show the spliced mRNAs.
Fig. 2. eIF4A3 is essential for loading Y14/Magoh and for EJC core assembly on splicedmRNA. (A)4A3NE cannot load Y14/Magoh ontomRNAduring splicing.
GSTpull-downassayswereperformedafter in vitro splicingof-globinpre-mRNAusingmock-depletedor4A3NE. The input andpull-down samples are shown:
lanes 1–4, GST alone; lanes 5–8, GST-Y14/His-Magoh; lanes 9–12, GST-eIF4A3. (B) Adding back recombinant eIF4A3 to 4A3 NE fully restores loading of
Y14/Magoh onto spliced mRNA. GST-Y14/His-Magoh pull-down was carried out from mock-depleted NE (lane 11) and from 4A3 NE (lanes 12–16). Purified
recombinant His-tagged eIF4A3 (10, 20, 50, 100, and 200 ng) was added to reactions containing 20 l of 4A3 NE (lanes 12–16). A total of 20 l of untreated
NE has 400 ng of eIF4A3. (C) Comparison of different eIF4A3 mutants or the Drosophila ortholog (200 ng each) in restoring the Y14/Magoh-loading activity
to 4A3 NE. The mRNA pull-down efficiency is indicated below the relevant lanes.








N-terminally truncated form of eIF4A3 was totally inactive (Fig.
2C, lane 15). This result is consistent with a previous report that the
helicase activity of eIF4A3 is not required for EJC assembly and
NMD (19). Interestingly, in the absence of human eIF4A3, Dro-
sophila eIF4A3 [which is 84% identical and is dispensable for NMD
in S2 cells (22)] could functionally replace its human ortholog for
loading Y14/Magoh (Fig. 2C, lane 16), suggesting that loading of the
EJC during pre-mRNA splicing may be an evolutionarily acquired
function of the human spliceosome, or, alternatively, that the
coupling of the EJC to NMD has been lost in Drosophila. We
performed a similar EJC assembly assay using Drosophila S2 cell
NE and observed a strong association of eIF4A3 with pre-mRNA,
in contrast to HeLa NE (SI Fig. 8).
Loading of Other EJC and Associated Components in the Absence of
eIF4A3. Multiple components of the EJC have been identified
biochemically (3, 4). To investigate whether these EJC factors can
still bind mRNA after eIF4A3 depletion, we again used GST
pull-down assays in conjunction with in vitro splicing. We first
purified GST-tagged Aly/REF, UAP56, RNPS1, SELOR [speckle
localizer and RNA binding module, a conserved domain of MLN51
(27)], Upf3b, and Upf3a. We then added these proteins to in vitro
splicing reactions with either mock-depleted or eIF4A3-depleted
NE. In the absence of eIF4A3, all of these proteins were still loaded
onto spliced mRNA (Fig. 3), indicating that different mechanisms
are responsible for loading of these factors onto mRNA, compared
with Y14/Magoh, which requires eIF4A3 for loading. Aly/REF,
UAP56, RNPS1, MLN51 (SELOR), and Upf3b/3a not only pulled
down the spliced mRNA, but, unlike eIF4A3, they also efficiently
pulled down the pre-mRNA, again indicating that the loading of
these factors may proceed separately and by a different mechanism
from the loading of the EJC core. We also found that, unlike
eIF4A3, these five factors could bind mRNA independently of
splicing (data not shown).
MLN51 is one of the components of the stable EJC core
[although its presence in the EJC has been questioned in a recent
report (23)], and the crystal structure of its SELOR domain (amino
acids 137–283) was recently solved (9, 10). eIF4A3 directly contacts
the bound RNA in the crystal structure, but Phe-188 of SELOR
stacks with an RNA base, suggesting that MLN51 enhances the
overall RNA-binding affinity of the complex. Moreover, the
SELOR domain by itself can bind RNA independently of splicing
(24). GST–SELOR associated with mRNA and pre-mRNA in the
presence or absence of eIF4A3 (Fig. 3A, lanes 8, 12, 20, and 24).
Therefore, in addition to its association with eIF4A3, MLN51 is
likely to simultaneously and directly bind RNA in the natural
mRNP complex. Although SELOR bound both pre-mRNA and
mRNA, the latter was considerably enriched in our pull-down assay,
indicating that MLN51 may bind to pre-mRNA first, and only then
interact with eIF4A3 and Y14/Magoh to form a stable EJC core
after splicing. The resulting complex formed during splicing may
bind mRNA more tightly, compared with the initial interaction with
the pre-mRNA. Consistent with this notion, when we allowed the
complex to assemble during splicing, and then increased the salt
concentration in the washing step, we pulled down much less
pre-mRNA compared with mRNA (Fig. 3A, lanes 8 and 12). In the
absence of eIF4A3, the RNA-binding affinity of SELOR in high salt
(500 mM KCl) was reduced (Fig. 3A, compare lanes 20 and 24),
again suggesting that the assembled EJC enhances or stabilizes
RNA binding by MLN51.
Using RNase H protection, we found that Upf3b, Upf3a,
MLN51, Aly/REF, UAP56, and RNPS1 bound both the 5 and 3
fragments of the cleaved mRNA in the presence or absence of
eIF4A3 (SI Fig. 9 and data not shown), indicating that, unlike
binding of the EJC core, binding of MLN51 or Upf3b to mRNA is
not restricted to 20–24 nt upstream of the exon–exon junction.
Stable EJC Assembly onto mRNA Takes Place at the Late Stages of
Splicing and Is Coupled with mRNA Release Mediated by HRH1/Prp22.
To address when and how eIF4A3 is recruited and assembled into
the EJC, relative to discrete steps in splicing catalysis, we used a
mutant substrate that can only undergo the first step of splicing (21).
This human -globin minigene transcript has a shortened exon 2,
an improved polypyrimidine track, and an AG to GG mutation at
the 3 splice site to block the second transesterification step (25).
When we used a control pre-mRNA with a WT AG dinucleotide
(WT-AG), the GST pull-down products for each protein were
similar to those we observed above with the standard -globin
pre-mRNA (Fig. 4A, lanes 1–12; compare with Fig. 3 and SI Fig.
7A). Y14/Magoh and eIF4A3 mainly pulled down spliced mRNA
(Fig. 4A, lanes 8 and 9), as did Aly/REF, albeit with somewhat
lower specificity (Fig. 4A, lane 11). RNPS1 preferentially pulled
down pre-mRNA and lariat product (Fig. 4A, lane 10). Upf3b
pulled down all of the RNA species (Fig. 4A, lane 12). For the 3
splice site mutant substrate (mut-GG), because the splicing reaction
is blocked after the first catalytic step, if eIF4A3 and other core EJC
components have already been assembled into a stable complex on
the pre-mRNA or intermediates at this stage, we would expect to
pull down these RNA species. However, we observed that eIF4A3
and Y14/Magoh could not pull down the mut-GG pre-mRNA and
first-step intermediates, indicating that the core components of the
EJC are still loosely associated with the spliceosome and have not
yet been loaded onto the RNA. RNPS1, Aly, and Upf3b pulled
down the pre-mRNA, indicating that these factors are already
stably associated with the pre-mRNA at this stage.
To further test when eIF4A3 is loaded, we purified the spliceo-
some by adding two MS2-binding sites at the 3 end of the two
splicing substrates. We then used purified MS2-GST fusion protein
to pull down the in vitro-assembled spliceosomes and probed the
Fig. 3. Other EJC-associated factors bind tomRNA independently of eIF4A3.
(A) eIF4A3 is not required for binding of MLN51 to mRNA but enhances its
association with mRNA after splicing. GST pull-down assays were carried out
from splicing reactions with -globin pre-mRNA in the presence of GST–
SELOR, GST-Y14/His-Magoh (GY/HM), or GST-eIF4A3 in either mock-depleted
NE (lanes 1–12) or eIF4A3 NE (lanes 13–24). After washing with 150 mM KCl
buffer (lanes 5–8 and 17–20) or 500mMKCl buffer (lanes 9–12 and 21–24), the
bound RNA was recovered and analyzed by denaturing PAGE and autora-
diography. LoadingofUAP56andAly/REF (B), RNPS1 (C), andUpf3bandUpf3a
(D) ontomRNAduring splicing is notaffectedbydepletionofeIF4A3.All of the
testedproteinswereGST-tagged. Fifteenpercent to 20%of each reactionwas
loaded in the input lanes.
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recovered material by Western blotting. We detected much more
eIF4A3 and Y14 using the WT-AG substrate than the mut-GG
substrate (SI Fig. 10), again indicating that eIF4A3 and Y14 are not
yet assembled into a stable complex before the second step of
splicing.
The splicing factor HRH1 and its yeast homologue, Prp22, which
are ATP-dependent RNA helicases, play dual roles at the late
stages of splicing: ligation of the two exons to form mature mRNA
in an ATP-independent manner and release of the spliced mRNA
from the spliceosome in an ATP-dependent manner (26). To
determine whether the EJC assembles onto mRNA after exon
ligation but before mRNA release, we took advantage of an
HRH1/Prp22 ATPase/helicase dominant-negative mutant, ‘‘LAT’’
(Ser-717 to Leu), which supports exon ligation but blocks the
release of spliced mRNA (27, 28). We purified WT and LAT
HRH1 proteins expressed in 293E cells, added them to in vitro
splicing reactions, and confirmed that the LAT mutant indeed
inhibits mRNA release from the spliceosome (SI Fig. 11A).
We then tested whether the LAT mutant affects EJC assembly
when mRNA release is blocked. Using the WT-AG substrate,
loading of both Y14/Magoh and eIF4A3 was significantly reduced
in the presence of LAT, from 20% pull-down efficiency (Fig. 4B,
lanes 5 and 6) to 2% (Fig. 4B, lanes 11 and 12). The same result was
obtained with the standard -globin pre-mRNA (SI Fig. 11B).
These data suggest that the EJC is not assembled onto spliced
mRNA before the mRNA’s release from the spliceosome.
To rule out the possibility that the EJC is actually assembled onto
the mRNA but is buried within the spliceosome in such a way that
the GST tag is not accessible, we used the above -globin derivative
with two MS2-binding sites at the end of exon 2. We added DNA
oligonucleotides complementary to the intron sequence to allow
endogenous RNase H to cleave contaminating pre-mRNA (21). In
the presence of the LAT HRH1 mutant, the GST-MS2-bound
mRNA represented 50% of the amount recovered when WT
HRH1 was added to the reaction (Fig. 4C, lanes 5 and 6). The 3
half of the cleaved pre-mRNA containing the MS2 sites was also
pulled down. We then analyzed the purified mRNP (plus the
3-cleaved product from pre-mRNA) by Western blotting (Fig. 4D).
The mRNP generated in the presence of WT HRH1 contained
10-fold more eIF4A3 than the mRNP generated in the presence
of the LAT mutant, whereas there was only a slight difference in the
amount of Aly/REF (Fig. 4D, lanes 2 and 3). We conclude that the
mRNA that has not yet been released lacks an assembled EJC core.
Thus, the spliceosome may undergo an ATP-dependent confor-
mational change to release the spliced mRNA and to provide the
assembly site for deposition of the EJC core at the exon–exon
junction.
Discussion
We have carried out a series of biochemical assays to address
several questions about the function of eIF4A3 in pre-mRNA
splicing and in splicing-dependent EJC assembly and mRNP
remodeling. We provided evidence that eIF4A3 is not required
for constitutive pre-mRNA splicing but is essential for assembly
of the EJC core, particularly for loading the Y14/Magoh het-
erodimer onto mRNA in a splicing-dependent manner. We
found that other EJC-associated factors, such as MLN51, Aly/
REF, UAP56, Upf3b/3a, and RNPS1, can bind mRNA inde-
pendently of eIF4A3, in contrast to previous suggestions that the
EJC core is responsible for recruitment of these factors onto
mRNA (4). This eIF4A3-dependent and -independent recruit-
ment of different mRNA-binding proteins onto the mRNA
during splicing suggests that the mRNP architecture undergoes
a rearrangement through interactions among each EJC and
other preloaded mRNA-binding proteins. The resulting confor-
mation of the mRNP might influence downstream events, such
as mRNA export, translation, and NMD. We also found that
eIF4A3 is assembled onto the EJC late in the splicing reaction,
and the final deposition of the EJC onto mRNA requires the
helicase activity of the mRNA-release factor HRH1.
The Role of EJC Core Components in Pre-mRNA Splicing and Their
Association with the Spliceosome. The composition of human spli-
ceosomal complexes has been extensively studied, and 200 spli-
ceosomal proteins have been identified (14, 15). Several groups
found the EJC core components Y14/Magoh and eIF4A3 in the
spliceosome, but whether these factors are involved in pre-mRNA
splicing was unclear. We immunodepleted the EJC core component
eIF4A3 from HeLa NE and found that eIF4A3-depleted NE is fully
functional in splicing, indicating that the EJC core is dispensable for
constitutive pre-mRNA splicing. We cannot rule out that residual
amounts of eIF4A3 might support splicing of the various pre-
mRNAs, but we think that this is very unlikely. First, the extent of
eIF4A3 depletion was sufficient to abrogate loading of Y14/Magoh.
Second, there was no difference in splicing efficiency between
mock- and eIF4A3-depleted NE when we used higher amounts of
pre-mRNA (data not shown). Another formal possibility is that
other factors may replace eIF4A3 in splicing, e.g., other spliceoso-
mal RNA helicases.
Fig. 4. Loading of eIF4A3 and assembly of the EJC core onmRNAoccur at the
late stages of splicing and require the helicase activity of HRH1/Prp22. (A) In
vitro splicing and GST pull-down using WT (WT-AG; lanes 1–12) and 3 splice
sitemutant (Mut-GG; lanes 13–24) pre-mRNAs. TheGST fusion proteins added
to each reaction are indicated above each lane. The mobilities of the splicing
precursor, intermediates, and products are shown on the right. The Mut-GG
substrate can undergo only the first step of splicing. (B) In vitro splicing and
GST pull-down in the presence of WT (lanes 1–6) or LAT-mutant HRH1 (lanes
7–12) (200 ng). The mRNA pull-down efficiency is indicated below the gel. (C)
Purification of in vitro-assembled mRNPs after splicing using -globin pre-
mRNA with two MS2-binding sites at the 3 end of exon 2. Splicing reactions
were incubatedwithGST-MS2 in the presence ofWTor LATHRH1 (lanes 1 and
2). After 3 h, DNA oligonucleotides complementary to the intronwere added,
and incubationwas continued for 20min (lanes 3 and 4).mRNPswere purified
on glutathione-Sepharose, and bound RNAs were extracted and analyzed by
denaturing PAGE (lanes 5 and 6). The purified 3-cleaved products from
pre-mRNA are also labeled (lanes 5 and 6). (D) Proteins from the purified
mRNPs from B (lanes 5 and 6) were analyzed by Western blotting using
antibodies against eIF4A3 and Aly/REF.








Our observation that eIF4A3 is dispensable for splicing provides
further evidence supporting an additional role of the splicing
machinery (besides removing introns) in facilitating the loading of
various RNA-binding proteins, e.g., the EJC, or altering the re-
versible modification state of some mRNA-bound proteins during
splicing (2). This mRNP remodeling may affect the fate of the
mRNA by altering the mRNP structure, and/or through interac-
tions between the loaded proteins and other molecules. It is widely
believed that the fate of an mRNA is mainly determined by its
associated proteins (29), and an mRNA that has undergone splicing
is clearly distinct from an mRNA with identical sequence that is
transcribed from an intronless cDNA (30, 31).
Recruitment of EJC Core Components onto mRNA and EJC Assembly.
We have shown here that the assembly of the EJC proceeds in a
stepwise manner: some of the factors are loaded onto pre-mRNA
first, and others bind only to the mRNA after splicing, which is
consistent with previous work (32). Among the EJC core compo-
nents, MLN51 appears to bind RNA nonspecifically via its SELOR
domain. This binding is not splicing-dependent, because we showed
that SELOR binds both pre-mRNA and mRNA. We speculate that
MLN51 may bind pre-mRNA on its own, subsequently becoming
associated with eIF4A3 on the spliced mRNA. After splicing is
completed, eIF4A3 binds specifically to the mRNA upstream of the
exon–exon junction, and the loading of eIF4A3 provides a binding
surface for loading of Y14/Magoh onto mRNA. Then the prebound
MLN51 may join in to form the stable core of the EJC, which in turn
can interact with other mRNA-binding proteins that may be already
preloaded onto the mRNA, such as Upf3b/3a, to establish a specific
mRNP architecture. MLN51 interacts with the EJC component
Magoh in a partially RNase-sensitive manner (24). We found that,
in the absence of eIF4A3, loading of MLN51 onto mRNA is only
slightly reduced, but not abolished, in contrast to loading of
Y14/Magoh, which is strongly inhibited. This finding suggests that
MLN51 can directly bind RNA independently of the EJC, and its
additional interaction with eIF4A3-Y14/Magoh can stabilize the
EJC core complex.
eIF4A3 and other EJC factors can be detected in the purified
spliceosomal C complex by mass spectrometry (15, 23). Our data
indicate that the final assembly of the EJC core takes place after the
second step of splicing. We expect that eIF4A3 is recruited by the
spliceosome before the second step of splicing but is only loosely
associated with the complex. In this scenario, before the second step
of splicing, eIF4A3 and other EJC factors may not have been
assembled into a stable complex on the mRNA, and thus they would
be readily dissociated during our purification. Therefore, we think
that stable assembly of the EJC core complex (as opposed to initial
recruitment) takes place during or after the second step of splicing.
Our data further demonstrate that the helicase activity of the
mRNA-release factor HRH1 is required for assembly of the EJC on
the mRNA after splicing, indicating that EJC assembly occurs in
conjunction with the mRNA’s release from the spliceosome. In the
spliceosomal C complex, the EJC assembly site near the exon–exon
junction region is buried, as the last 30 nt of the first exon are
protected from RNase H (15). HRH1 releases the spliced mRNA
from the spliceosome in an ATP-dependent manner and exposes
the binding site for EJC assembly. Hence, HRH1 may facilitate
extensive rearrangements near the exon–exon junction, leading to
the final release of the spliced mRNA and the deposition of the EJC
upstream of the exon–exon junction.
Aly/REF, RNPS1, and Upf3b/3a appear to be loaded onto
mRNA by a different mechanism(s) compared with eIF4A3 and
Magoh/Y14. They bind not only to the mRNA, but to the pre-
mRNA as well, whether directly or indirectly, or perhaps nonspe-
cifically in the context of the prespliceosomal H complex. RNPS1,
which is also a general splicing activator, bound preferentially to the
pre-mRNA (33). Aly/REF and Upf3b/3a also bound both pre-
mRNA and mRNA, but we observed an enrichment for the mRNA
in the GST pull-down assays, suggesting that the splicing machinery
can facilitate the loading of these factors onto mRNA (or stabilize
their preexisting interactions) during splicing. This might reflect
splicing-dependent EJC formation, which would stabilize the bind-
ing of these proteins onto mRNA through their interactions with
the EJC core. It was recently demonstrated that Aly/REF actually
binds mRNA upstream of the EJC and forms a stable complex with
the CBC (cap-binding complex) and TREX (transcription/export)
complex at the mRNA 5 end that plays a critical role in directing
mRNA nuclear export (34).
The EJC-independent binding of Upf3b/3a onto mRNA was
unexpected, because the RRM (RNA-recognition motif) of Upf3b
interacts with Upf2 instead of binding RNA (35). Using a pull-down
assay, we found that full-length Upf3b can bind RNA directly (data
not shown), but, in light of its very basic character, we do not know
whether Upf3b binds mRNA in vivo by direct RNA–protein
interaction or through a more elaborate mechanism.
Remodeling of the mRNP by the EJC and Implications for NMD.
Although most NMD factors are conserved, the mechanisms of
NMD appear to be distinct in different species, particularly with
respect to how the premature termination codon (PTC) is recog-
nized and distinguished from the normal stop codon (36). NMD
requires active translation, and it is thought that cross-talk between
the stalled ribosome at a PTC and a downstream feature of the
mRNA somehow triggers the NMD response. In yeast and Dro-
sophila, the distance between the PTC and the 3 UTR appears to
be critical. In humans, the exon–exon junction boundary and the
splicing-dependent assembly of the EJC play important roles (36).
In mammalian cells, the prevailing model proposes that the depo-
sition of the EJC during splicing is followed by the recruitment of
Upf3b/3a, which in turn interact with Upf2 and Upf1. These
proteins form a surveillance complex downstream of the PTC.
Cross-talk between this complex and the translation–termination
complex when the ribosome reaches the stop codon defines the
PTC by an unknown mechanism, triggering the rapid degradation
of the target message (37).
Our GST pull-down results are inconsistent with the current
EJC-centric model of mRNP assembly (4), according to which it is
the assembled EJC core that recruits other factors (Upf3b, Upf3a,
RNPS1, and Aly/REF) onto spliced mRNA. We propose instead
that these factors can bind to both pre-mRNA and mRNA even
before the EJC core is formed. After splicing is completed and the
EJC core is assembled, these factors may establish contacts with the
EJC through specific protein–protein interactions to form a func-
tional mRNP structure, although at the same time they may retain
contacts with other regions of the mRNA.
Our data also suggest that the Upf proteins may actually not be
recruited to the mRNA by the EJC during splicing. For instance,
Upf3b/3a appear to be preloaded onto the mRNA even before the
EJC is assembled. We also found that Upf3b/3a alone have
nonspecific RNA-binding activity (data not shown). Both Upf1 and
Upf2 bind RNA nonspecifically as well (35, 38). Considering that
splicing and EJC loading are required for NMD in mammalian
cells, we propose that, after the EJC is loaded onto mRNA, this
complex can interact with other mRNA-binding proteins that are
already prebound, such as Upf3b/3a, resulting in remodeling of the
mRNP conformation. This EJC-directed mRNP remodeling would
alter both the local and the overall structure or conformation of the
mRNP. The ultimate functional structure may be critical for the
downstream fate of the mRNA. Because eukaryotic genes usually
contain multiple introns, multiple EJCs can be loaded onto a fully
spliced mRNA (34). Each prebound protein on the mRNA may
interact with an EJC that is either downstream or upstream,
potentially resulting in conformational heterogeneity of the mRNP.
When an mRNA harbors a PTC and a translating ribosome reaches
it, the local mRNP composition and structure around the PTC may
enable the ribosome-termination complex to recognize this stop
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codon as an abnormal one. Because of the likely heterogeneity of
mRNP structures, some of them may make the PTC easily recog-
nizable; some may cause the recognition of the PTC to be less
efficient; and others may mask the PTC in such a way that the
mRNA can escape NMD. This heterogeneity may explain why
NMD is seldom 100% efficient and why some PTC-containing
mRNAs are immune to NMD (39).
For many PTC-containing transcripts, when the distance be-
tween the PTC and the last EJC is 50–55 nt, the mRNA can
escape NMD, although the reason for this is not known (37). Based
on our model, we speculate that this minimal distance constraint
may reflect an unfavorable mRNP conformation around such a
PTC. Because an elongating ribosome should displace the bound
proteins on the mRNA, when it reaches a PTC located very close
to the last EJC, the complex interactions between the EJC and the
various upstream-bound proteins would already have been dis-
rupted. This may cause a profound change in the local mRNP
conformation, which might lead to an unrecognizable PTC.
Concerning the polarity of NMD (40), i.e., the finding that the
strength of NMD correlates with the position of the PTC, such that
PTCs proximal to the downstream terminal intron tend to elicit
robust NMD effects, it is also conceivable that the local mRNP
conformation and composition may determine the strength of the
NMD effect. A recent report showed that improving the splicing
efficiency of an intron downstream of a PTC elicits stronger NMD
compared with a weak intron at the same position (41). More
efficient and rapid loading of the EJC may account for this
NMD-promoting effect by splicing of a particular intron. Based on
our model, we think that the spliceosome can remodel the mRNP
architecture as splicing of each intron takes place, and thereafter.
The timing of each splicing event may therefore influence the local
mRNP structure. It is also known that the position of an intron
within a gene can affect the fate of the mRNA (30, 42). We can
therefore imagine that the intron position dictates where the EJC
is deposited, which in turn alters the local or overall mRNP
architecture, with consequent effects on translation, localization,
export, and turnover of the mRNA.
Materials and Methods
Protein Expression and Purification. All plasmids are described in
SI Materials and Methods. GST-eIF4A3 was expressed in and
purified from E. coli strain BL21-DE3(pLysS) using
glutathione-Sepharose beads. GST-RNPS1 and GST-Upf3b/3a
were expressed in and purified from HEK-293E cells (43).
GST-Y14/His-Magoh was purified as described (44). The WT
and LAT-mutant HRH1 proteins were overexpressed in 293E
cells and purified on Ni-NTA agarose beads. The proteins were
dialyzed against buffer D (45).
In Vitro Splicing, Immunodepletion, and RNA GST Pull-Down. In vitro
splicing was performed as described (45). For RNA GST pull-
downs, 4 g of GST fusion protein was added to a 50-l splicing
reaction. After 2 h, 5–10 l was kept as the input control; 10 l of
glutathione beads was added to the remainder, and the volume was
increased to 400 l with washing buffer [20 mM Hepes, pH 8.0/150
mM KCl/0.05% (vol/vol) Nonidet P-40]. After rocking for 1–2 h at
4°C, the beads were washed four times with cold washing buffer.
After addition of 300 l of stop solution (45), the RNA was
recovered by phenol extraction and ethanol precipitation. Immu-
nodepletion was carried out as described (46).
Spliceosome Purification and Western Blotting. One microgram of
32P-labeled pre-mRNA (WT-MS2 and Mut-GG-MS2) was incu-
bated in a 1-ml splicing reaction with 12 g of GST-MS2 protein.
Spliceosomal complexes were affinity-purified on glutathione-
Sepharose. The beads were washed four times; 1/10th was used for
RNA analysis, and the rest was used for Western blotting.
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